How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density

Ng, 2005, Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice, BJU Int, 95, 545, 10.1111/j.1464-410X.2005.05336.x Aminsharifi, 2018, Prostate specific antigen density as a predictor of clinically significant prostate cancer when the prostate specific antigen is in the diagnostic gray zone: defining the optimum cutoff point stratified by race and body mass index, J Urol, 200, 758, 10.1016/j.juro.2018.05.016 Wei, 2023, Early detection of prostate cancer: AUA/SUO guideline part ii: considerations for a prostate biopsy, J Urol Ahmed, 2017, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1 Byun, 2022, The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naive men according to PSA levels: a propensity score matching analysis, Prostate Int, 10, 45, 10.1016/j.prnil.2021.10.002 Radtke, 2015, Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance, Prostate Cancer Prostatic Dis, 18, 288, 10.1038/pcan.2015.29 Kesch, 2018, Multiparametric MRI fusion-guided biopsy for the diagnosis of prostate cancer, Curr Opin Urol, 28, 172, 10.1097/MOU.0000000000000461 Kasivisvanathan, 2018, MRI-targeted or standard biopsy for prostate-cancer diagnosis, N Engl J Med, 378, 1767, 10.1056/NEJMoa1801993 Rouviere, 2019, Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study, Lancet Oncol, 20, 100, 10.1016/S1470-2045(18)30569-2 Loeb, 2015, The prostate health index selectively identifies clinically significant prostate cancer, J Urol, 193, 1163, 10.1016/j.juro.2014.10.121 Druskin, 2018, Combining prostate health index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer, BJU Int, 121, 619, 10.1111/bju.14098 Ferro, 2021, Prostate health index and multiparametric MRI: partners in crime fighting overdiagnosis and overtreatment in prostate cancer, Cancers (Basel), 13, 10.3390/cancers13184723 Epstein, 2016, The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system, Am J Surg Pathol, 40, 244, 10.1097/PAS.0000000000000530 Ito, 2013, Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, World J Urol, 31, 305, 10.1007/s00345-012-0927-9 Mearini, 2014, Evaluation of prostate-specific antigen isoform p2PSA and its derivates, %p2PSA, prostate health index and prostate dimension-adjusted related index in the detection of prostate cancer at first biopsy: an exploratory, prospective study, Urol Int, 93, 135, 10.1159/000356240 Filella, 2022, Value of PHI and PHID in the detection of intermediate- and high-risk prostate cancer, Clin Chim Acta, 531, 277, 10.1016/j.cca.2022.04.992 Tosoian, 2017, Prostate Health Index density improves detection of clinically significant prostate cancer, BJU Int, 120, 793, 10.1111/bju.13762 Schoots, 2018, MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?, Transl Androl Urol, 7, 70-+, 10.21037/tau.2017.12.31 Liddell, 2015, mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer - a retrospective review of 92 biopsied PIRADS 3 Lesions, BJU Int, 115, 95 Hermie, 2019, Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center, Eur J Radiol, 114, 92, 10.1016/j.ejrad.2019.02.031 Washino, 2017, Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naive patients, BJU Int, 119, 225, 10.1111/bju.13465 Lee, 2022, Clinical utility of prostate health index for diagnosis of prostate cancer in patients with PI-RADS 3 Lesions, Cancers (Basel), 14 Lee, 2022, Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1-2 on multiparametric magnetic resonance imaging, Prostate Int, 10, 56, 10.1016/j.prnil.2021.08.003 Filella, 2014, The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10 mu g/L, Clin Chim Acta, 436, 303, 10.1016/j.cca.2014.06.019